These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9513799)

  • 21. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
    Alho H; Sinclair D; Vuori E; Holopainen A
    Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
    Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
    Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans.
    Vaupel DB; Lange WR; London ED
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1386-94. PubMed ID: 8263800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
    White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
    Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study.
    Rosen MI; Pearsall HR; McDougle CJ; Price LH; Woods SW; Kosten TR
    Am J Drug Alcohol Abuse; 1993; 19(4):451-64. PubMed ID: 8273766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of secondary buprenorphine (Temgesic) dependence].
    Benos J
    Nervenarzt; 1983 May; 54(5):259-61. PubMed ID: 6866170
    [No Abstract]   [Full Text] [Related]  

  • 29. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine.
    Mannelli P; Janiri L; Tempesta E; Jones RT
    Br J Psychiatry Suppl; 1993 Sep; (21):39-45. PubMed ID: 8217067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).
    Welsh C; Sherman SG; Tobin KE
    Addiction; 2008 Jul; 103(7):1226-8. PubMed ID: 18554353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differences in the subjective effects of drugs in patients with a first psychotic episode. Preliminary results].
    Busquets E; Torrens M; Soler A; Farré M; Bulbena A
    Actas Esp Psiquiatr; 2005; 33(1):19-25. PubMed ID: 15704027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
    Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
    Comer SD; Sullivan MA; Whittington RA; Vosburg SK; Kowalczyk WJ
    Neuropsychopharmacology; 2008 Apr; 33(5):1179-91. PubMed ID: 17581533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine reduces cerebral glucose metabolism in polydrug abusers.
    Walsh SL; Gilson SF; Jasinski DR; Stapleton JM; Phillips RL; Dannals RF; Schmidt J; Preston KL; Grayson R; Bigelow GE
    Neuropsychopharmacology; 1994 May; 10(3):157-70. PubMed ID: 7916913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment.
    Branstetter SA; Bower EH; Kamien J; Amass L
    J Subst Abuse Treat; 2008 Mar; 34(2):208-14. PubMed ID: 17596905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.